Melanoma in the young: new study seeks answers

NCT ID NCT06994208

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study is looking at 25 adults aged 18 to 39 who have been diagnosed with melanoma. Researchers want to find out how common melanoma is in this age group and identify risk factors, skin features, and genetic changes linked to the disease. The goal is to better understand melanoma in younger people, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help identify risk factors and genetic markers for melanoma in young adults, potentially improving early detection and prevention strategies.

What could go wrong

This is a small, single-center observational study with only 25 participants, so findings may not apply to broader populations. It does not test any treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA OF SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • E.O. Ospedali Galliera

    RECRUITING

    Genoa, Liguria, 16128, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••